FULL PUBLIC NOTICE
Department of Health
MRT 1115 Waiver Extension Request
- Notice is also available in Portable Document Format (PDF)
In compliance with 42 CFR 431.408(a)(1) as well as the current MRT Waiver Special Terms and Conditions regarding the annual Public Forum requirement, the New York State Department of Health is pleased to announce that it will conduct two virtual public hearings/public forums, to provide an overview of the State´s 1115 waiver extension request and allow members of the public to provide comments. This notice further serves to open the 30-day public comment period which will close on Friday, January 15, 2021. In addition to this 30-day comment period where the public will be afforded the opportunity to provide written comments, the Department of Health will be hosting two virtual public hearings during which the public may provide oral comments. Any updates related to the public hearings and forum will be sent via the MRT ListServ.
The two virtual public hearing/public forum meetings will be held as follows:
- First Public Hearing/Public Forum
- Thursday, January 21, 2021 from 1-4pm.
- Pre-registration is required for anyone wishing to provide oral comment using this link.
- Individuals who wish to provide comment will need to register with an "SP" in front of their name (ex: SP Jane Doe) and must email 1115waivers@health.ny.gov no later than Wednesday, January 20, 2021 at 4pm to confirm registration.
- Individuals will speak in their order of registration. We kindly request that all comments be limited to five minutes per presenter to ensure that all public comments may be heard.
- Second Public Hearing/Public Forum
- Wednesday, January 27, 2021 from 1-4pm.
- Pre-registration is required for anyone wishing to provide oral comment using this link.
- Individuals who wish to provide comment will need to register with an "SP" in front of their name (ex: SP Jane Doe) and must email 1115waivers@health.ny.gov no later than Tuesday, January 26, 2021 at 4pm to confirm registration.
- Individuals will speak in their order of registration. We kindly request that all comments be limited to five minutes per presenter to ensure that all public comments may be heard.
Prior to finalizing the proposed MRT Waiver extension application, the Department of Health will consider all written and verbal comments received. These comments will be summarized and addressed in the final version that is submitted to CMS.
Extension Proposal Summary and Objectives
The New York State Department of Health ("NYSDOH") is requesting a three-year extension of the existing Section 1115 Medicaid Redesign Team ("MRT") waiver demonstration, which is set to expire on March 31, 2021. This extension proposal seeks an extension of all current programs and authorities in the State´s current waiver demonstration, with the following two programmatic amendments:
- Carveout of the Non-Emergency Medical Transportation (NEMT) Benefit for Managed Long-Term Care Members to Fee-For-Service: The goals of this amendment request are as follows:
- Improve administrative simplification by creating a consistently managed transportation benefit and removing the benefit from the MRT Waiver;
- Reduce cost-risk by shifting the broker arrangement to a risk-based arrangement; and
- Create a larger pool of members by combining all members, except PACE for which the transportation benefit must be managed by the PACE Organization under federal rules, for brokers to provide NEMT service to.
- Carveout of Pharmacy Benefits from Medicaid Managed Care to Fee-For-Service. The goals of this amendment request are as follows:
- Provide the State with full visibility into prescription drug costs;
- Centralize and leverage negotiation power;
- Provide a single drug formulary with standardized utilization management protocols; and
- Address the growth of the 340B program and associated reductions in State rebate revenue.
These amendments were developed by the State´s Medicaid Redesign Team II (MRT II), and are part of a larger, more comprehensive set of reforms that the State is planning to innovate and improve the Medicaid program. MRT II brought together a comprehensive set of stakeholders to collectively find solutions that improve the delivery of care and outcomes for Medicaid members and contain spending growth in the Medicaid program.
Eligibility, Benefits, and Cost-Sharing Changes
This extension proposal, inclusive of the two proposed amendments, contains no changes to eligibility, scope of benefits, or cost-sharing requirements. The two proposed amendments simply shift the administration and delivery of the two identified benefits by carving out these two benefits from the Medicaid Managed Care delivery systems to Fee-For-Service in the State Plan.
Enrollment and Fiscal Projections
This 1115 extension proposal is expected to have no or nominal impact on annual Medicaid enrollment, and is further expected to be budget neutral. The tables below illustrate historical caseloads and costs of the current waiver (Exhibit 1), as well as projected caseloads and costs of the demonstration as proposed (Exhibit 2).
Exhibit 1: Historical Caseloads and Costs (in total computable dollars) *
Demonstration Year | DY18 | DY19 | DY20 | DY21* | DY22* |
---|---|---|---|---|---|
Historical Caseload** | 4,903,302 | 4,883,361 | 5,170,656 | 5,472,989 | 5,738,303 |
Historical Cost | $47,739,999,038 | $47,739,999,038 | $47,739,999,038 | $47,739,999,038 | $47,739,999,038 |
*Includes projected data.
**Total historical cost figures as reported in the CY2020 Q3 submission of the Budget Neutrality Reporting Tool, WW Spending Total Tab.
**Caseload is based on total Member Months reported /12 (CY2020 Q3 submission of the Budget Neutrality Reporting Tool, MemMon Total Tab).
Exhibit 2: Projected Caseloads and Costs (in total computable dollars) *
Demonstration Year | DY23 | DY24 | DY25 |
---|---|---|---|
Projected Caseload of the Demonstration | 4.9 million | 4.9 million | 4.9 million |
MLTC Transportation Carveout Only | 0 | n/a | n/a |
Pharmacy Carveout Only | 0 | n/a | n/a |
Projected Cost | $51.2 billion | $53.5 billion | $56.0 billion |
MLTC Transportation Carveout Only | $16.6 million | n/a | n/a |
Pharmacy Carveout Only** | $698.1 million | n/a | n/a |
*The numbers above represent projected caseload and costs for the entire waiver proposal, as well as specific details related to the two proposed amendments.
**MLTC Transportation and Pharmacy Carveouts will not impact membership as neither carveout affects member eligibility.
***The costs below do not include a projection for MEG 9 (HCBS Expansion) and MEG 10 (Institute to Community).
Hypotheses and Evaluation
In July 1997, New York State (the "State") received approval from the Centers for Medicare and Medicaid Services ("CMS") for its "Partnership Plan" Medicaid Section 1115 Demonstration (the "1115 Demonstration"). In implementing the 1115 Demonstration, the State sought to achieve the following goals:
- Improve access to health care for the Medicaid population;
- Improve the quality of health services delivered;
- Expand access to family planning services; and
- Expand coverage to additional low-income New Yorkers with resources generated through managed care efficiencies.
The primary purpose of the Demonstration was to enroll a majority of the State´s Medicaid population into managed care; to use a managed care delivery system to deliver benefits to Medicaid recipients; to create efficiencies in the Medicaid program, and enable the extension of coverage to certain individuals who would otherwise be without health insurance. The MRT Waiver continues to meet the goals and objectives that were established at the initial approval of the demonstration.
The current hypotheses for the aforementioned goals are:
- The MRT Waiver will improve access to health care for the Medicaid population;
- The MRT Waiver will improve the quality of health services delivered;
- The MRT Waiver will expand access to family planning services; and
- The MRT Waiver will expand coverage to additional low-income New Yorkers with resources generated through managed care efficiencies.
Waiver and Expenditure Authorities
As specified in the MRT Waiver extension application, the State requests a continuation of the following waiver and expenditure authorities to operate the demonstration:
Waiver Authority | Reason and Use of Waiver Authority |
---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Title XIX Requirements Not Applicable to Self-Direction Pilot Program (see Expenditure Authority 6, "Self-Direction Pilot") | |
|
|
The State is requesting the use of the same expenditure authorities as approved in the existing 1115 demonstration, except for expenditure authority to provide incentive payments and planning grants for the previously numbered Expenditure Authority 7, Delivery System Incentive Reform Payment (DSRIP) program, which are expiring in March of 2020, or previously numbered Expenditure Authority 6, Designated State Health Program Funding, which expired in 2020. While the State is not requesting the use of the DSRIP Expenditure Authority, CMS provided additional authority to provide DSRIP administration and a schedule of PPS payments until 2021, this additional authority is not part of this extension request. The State requests the continuation of the remaining expenditure authorities and are as follows:
Waiver Authority | Reason and Use of Waiver Authority |
---|---|
|
Expenditures for healthcare related costs for the following populations that are not otherwise eligible under the Medicaid State Plan:
|
|
|
|
|
|
|
|
|
|
|
Submission and Review of Public Comments
A draft of the proposed MRT Waiver extension request available for review here. Due to COVID-19 pandemic, the Department of Health offices are operating at a reduced in-person capacity. For individuals with limited online access and require special accommodation to access paper copies, please call (518) 473-0919. While the State will be accepting physical written comments due to COVID-19, comments submitted electronically by email is preferred.
Prior to finalizing the proposed MRT Waiver extension application, the Department of Health will consider all written and verbal comments received. These comments will be summarized in the final submitted version. The Department will post a transcript of the public hearings, as well as any submitted written public comments, on the following website.
Please direct all questions to 1115waivers@health.ny.gov.
Written comments will be accepted by email at 1115waivers@health.ny.gov or by mail at:
Department of HealthOffice of Health Insurance Programs
Waiver Management Unit
99 Washington Ave.
7th fl. (Suite 720)
Albany, NY 12210
Follow Us